195 related articles for article (PubMed ID: 803252)
1. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Rosenberg SA; Kaplan HS
Cancer; 1975 Jan; 35(1):55-63. PubMed ID: 803252
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Rosenberg SA
Bibl Haematol; 1975; (40):731-5. PubMed ID: 1164407
[TBL] [Abstract][Full Text] [Related]
3. Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Brace K; Serpick AA; Block JB; Wiernik PH
Oncology; 1973; 27(6):484-92. PubMed ID: 4582588
[No Abstract] [Full Text] [Related]
4. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
5. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Rosenberg SA; Kaplan HS; Portlock CS; Glatstein EJ
Cancer; 1978 Aug; 42(2 Suppl):991-1000. PubMed ID: 99226
[TBL] [Abstract][Full Text] [Related]
7. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Bonadonna G; Zucali R; De Lena M; Valagussa P
Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
[No Abstract] [Full Text] [Related]
8. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
9. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
10. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
[TBL] [Abstract][Full Text] [Related]
11. [The current state of curability of Hodgkin's disease].
Streuli RA; Ultmann JE
Schweiz Med Wochenschr; 1981 Sep; 111(36):1301-3. PubMed ID: 7302531
[TBL] [Abstract][Full Text] [Related]
12. Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
Fuller LM; Gamble JF
JAMA; 1973 Jan; 223(2):168-9. PubMed ID: 4739457
[No Abstract] [Full Text] [Related]
13. Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation.
Kun LE; DeVita VT; Young RC; Johnson RE
Int J Radiat Oncol Biol Phys; 1976; 1(7-8):619-26. PubMed ID: 824248
[No Abstract] [Full Text] [Related]
14. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
15. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
Tubiana M; Mathé G
Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
[No Abstract] [Full Text] [Related]
16. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
17. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
18. Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
Goodman R; Mauch P; Piro A; Rosenthal D; Goldstein M; Tullis J; Hellman S
Cancer; 1977 Jul; 40(1):84-9. PubMed ID: 406981
[TBL] [Abstract][Full Text] [Related]
19. Prednisone in MOPP chemotherapy for Hodgkin's disease.
Jacobs C; Portlock CS; Rosenberg SA
Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
[TBL] [Abstract][Full Text] [Related]
20. Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
Gamble JF; Fuller LM; Ibrahim E; Butler JJ; Shullenberger CC
Arch Intern Med; 1973 Mar; 131(3):435-8. PubMed ID: 4688041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
